Novartis keeps CEO pay steady, but incoming chairman pay drops
BASEL (Reuters) - Novartis kept pay for its Chief Executive Joe Jimenez steady, after cutting it last year before a Swiss vote to force companies to accept shareholder limits on executive rewards.
Related Articles
- AIG Chairman Steve Miller to Step Down in July also written by Reuters
- Getting Gen-Y on Boards (of Directors) also categorized in BoardNews
- A Changed and Changing Executive Compensation Environment also mentions Disclosures on Compensation
- Taiwan Court Orders Reinstatement Of Two CPDC Board Candidates As Contested Vote Nears also categorized in BoardNews
- Coca-Cola Faces Renewed Pressure Over Executive Pay also written by Reuters
- Why Should We Care About Corporate Interlocks? also categorized in BoardNews
- Firms with female directors do better, study says also published in Chicago Tribune
- Two Shareholders Sue American Apparel Over CEO's Ouster also written by Reuters
- Netflix: Icahn Says Poison Pill 'Poor Corporate Governance' also categorized in BoardNews
- These Are The People Who Will Be Soaked In Cash After Twitter's IPO also written by Reuters
Login to comment.